<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2005-04-12" modified="2017-05-10" version="154">
<accession>Q9BYX4</accession>
<accession>Q2NKL6</accession>
<accession>Q6DC96</accession>
<accession>Q86X56</accession>
<accession>Q96MX8</accession>
<accession>Q9H3G6</accession>
<name>IFIH1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Interferon-induced helicase C domain-containing protein 1</fullName>
<ecNumber>3.6.4.13</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Clinically amyopathic dermatomyositis autoantigen 140 kDa</fullName>
<shortName>CADM-140 autoantigen</shortName>
</alternativeName>
<alternativeName>
<fullName>Helicase with 2 CARD domains</fullName>
<shortName>Helicard</shortName>
</alternativeName>
<alternativeName>
<fullName>Interferon-induced with helicase C domain protein 1</fullName>
</alternativeName>
<alternativeName>
<fullName>Melanoma differentiation-associated protein 5</fullName>
<shortName>MDA-5</shortName>
</alternativeName>
<alternativeName>
<fullName>Murabutide down-regulated protein</fullName>
</alternativeName>
<alternativeName>
<fullName>RIG-I-like receptor 2</fullName>
<shortName>RLR-2</shortName>
</alternativeName>
<alternativeName>
<fullName>RNA helicase-DEAD box protein 116</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">IFIH1</name>
<name type="synonym">MDA5</name>
<name type="synonym">RH116</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2002" name="Proc. Natl. Acad. Sci. U.S.A." volume="99" first="637" last="642">
<title>mda-5: an interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties.</title>
<authorList>
<person name="Kang D.-C."/>
<person name="Gopalkrishnan R.V."/>
<person name="Wu Q."/>
<person name="Jankowsky E."/>
<person name="Pyle A.M."/>
<person name="Fisher P.B."/>
</authorList>
<dbReference type="PubMed" id="11805321"/>
<dbReference type="DOI" id="10.1073/pnas.022637199"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>INDUCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Melanoma</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2003" name="J. Gen. Virol." volume="84" first="3215" last="3225">
<title>A novel cellular RNA helicase, RH116, differentially regulates cell growth, programmed cell death and human immunodeficiency virus type 1 replication.</title>
<authorList>
<person name="Cocude C."/>
<person name="Truong M.-J."/>
<person name="Billaut-Mulot O."/>
<person name="Delsart V."/>
<person name="Darcissac E."/>
<person name="Capron A."/>
<person name="Mouton Y."/>
<person name="Bahr G.M."/>
</authorList>
<dbReference type="PubMed" id="14645903"/>
<dbReference type="DOI" id="10.1099/vir.0.19300-0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>VARIANT ARG-843</scope>
<source>
<tissue>Spleen</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2)</scope>
<scope>VARIANTS ARG-843 AND THR-946</scope>
<source>
<tissue>Uterus</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 475-1025 (ISOFORM 1)</scope>
<scope>VARIANTS ARG-843 AND THR-946</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2002" name="Curr. Biol." volume="12" first="838" last="843">
<title>Overexpression of Helicard, a CARD-containing helicase cleaved during apoptosis, accelerates DNA degradation.</title>
<authorList>
<person name="Kovacsovics M."/>
<person name="Martinon F."/>
<person name="Micheau O."/>
<person name="Bodmer J.-L."/>
<person name="Hofmann K."/>
<person name="Tschopp J."/>
</authorList>
<dbReference type="PubMed" id="12015121"/>
<dbReference type="DOI" id="10.1016/S0960-9822(02)00842-4"/>
</citation>
<scope>MUTAGENESIS OF ASP-251 AND GLU-444</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2002" name="Curr. Biol." volume="12" first="1633" last="1633">
<authorList>
<person name="Kovacsovics M."/>
<person name="Martinon F."/>
<person name="Micheau O."/>
<person name="Bodmer J.-L."/>
<person name="Hofmann K."/>
<person name="Tschopp J."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Proc. Natl. Acad. Sci. U.S.A." volume="101" first="17264" last="17269">
<title>The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter.</title>
<authorList>
<person name="Andrejeva J."/>
<person name="Childs K.S."/>
<person name="Young D.F."/>
<person name="Carlos T.S."/>
<person name="Stock N."/>
<person name="Goodbourn S."/>
<person name="Randall R.E."/>
</authorList>
<dbReference type="PubMed" id="15563593"/>
<dbReference type="DOI" id="10.1073/pnas.0407639101"/>
</citation>
<scope>INTERACTION WITH PARAMYXOVIRUSES V PROTEIN</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2005" name="Nat. Immunol." volume="6" first="981" last="988">
<title>IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction.</title>
<authorList>
<person name="Kawai T."/>
<person name="Takahashi K."/>
<person name="Sato S."/>
<person name="Coban C."/>
<person name="Kumar H."/>
<person name="Kato H."/>
<person name="Ishii K.J."/>
<person name="Takeuchi O."/>
<person name="Akira S."/>
</authorList>
<dbReference type="PubMed" id="16127453"/>
<dbReference type="DOI" id="10.1038/ni1243"/>
</citation>
<scope>INTERACTION WITH MAVS/IPS1</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2005" name="Nature" volume="437" first="1167" last="1172">
<title>Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus.</title>
<authorList>
<person name="Meylan E."/>
<person name="Curran J."/>
<person name="Hofmann K."/>
<person name="Moradpour D."/>
<person name="Binder M."/>
<person name="Bartenschlager R."/>
<person name="Tschopp J."/>
</authorList>
<dbReference type="PubMed" id="16177806"/>
<dbReference type="DOI" id="10.1038/nature04193"/>
</citation>
<scope>INTERACTION WITH MAVS/IPS1</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2007" name="Proc. Natl. Acad. Sci. U.S.A." volume="104" first="7500" last="7505">
<title>Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125.</title>
<authorList>
<person name="Arimoto K."/>
<person name="Takahashi H."/>
<person name="Hishiki T."/>
<person name="Konishi H."/>
<person name="Fujita T."/>
<person name="Shimotohno K."/>
</authorList>
<dbReference type="PubMed" id="17460044"/>
<dbReference type="DOI" id="10.1073/pnas.0611551104"/>
</citation>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2007" name="Proc. Natl. Acad. Sci. U.S.A." volume="104" first="11706" last="11711">
<title>Negative regulation of MDA5- but not RIG-I-mediated innate antiviral signaling by the dihydroxyacetone kinase.</title>
<authorList>
<person name="Diao F."/>
<person name="Li S."/>
<person name="Tian Y."/>
<person name="Zhang M."/>
<person name="Xu L.G."/>
<person name="Zhang Y."/>
<person name="Wang R.P."/>
<person name="Chen D."/>
<person name="Zhai Z."/>
<person name="Zhong B."/>
<person name="Tien P."/>
<person name="Shu H.B."/>
</authorList>
<dbReference type="PubMed" id="17600090"/>
<dbReference type="DOI" id="10.1073/pnas.0700544104"/>
</citation>
<scope>INTERACTION WITH IKBKE; MAVS AND TKFC</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2009" name="Arthritis Rheum." volume="60" first="2193" last="2200">
<title>RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease.</title>
<authorList>
<person name="Sato S."/>
<person name="Hoshino K."/>
<person name="Satoh T."/>
<person name="Fujita T."/>
<person name="Kawakami Y."/>
<person name="Fujita T."/>
<person name="Kuwana M."/>
</authorList>
<dbReference type="PubMed" id="19565506"/>
<dbReference type="DOI" id="10.1002/art.24621"/>
</citation>
<scope>INVOLVEMENT IN CLINICALLY AMYOPATHIC DERMATOMYOSITIS</scope>
<scope>IDENTIFICATION AS CADM-140 AUTOANTIGEN</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="9700" last="9712">
<title>Regulation of signal transduction by enzymatically inactive antiviral RNA helicase proteins MDA5, RIG-I, and LGP2.</title>
<authorList>
<person name="Bamming D."/>
<person name="Horvath C.M."/>
</authorList>
<dbReference type="PubMed" id="19211564"/>
<dbReference type="DOI" id="10.1074/jbc.M807365200"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2009" name="J. Virol." volume="83" first="10761" last="10769">
<title>Activation of MDA5 requires higher-order RNA structures generated during virus infection.</title>
<authorList>
<person name="Pichlmair A."/>
<person name="Schulz O."/>
<person name="Tan C.P."/>
<person name="Rehwinkel J."/>
<person name="Kato H."/>
<person name="Takeuchi O."/>
<person name="Akira S."/>
<person name="Way M."/>
<person name="Schiavo G."/>
<person name="Reis e Sousa C."/>
</authorList>
<dbReference type="PubMed" id="19656871"/>
<dbReference type="DOI" id="10.1128/JVI.00770-09"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2009" name="Nat. Immunol." volume="10" first="1300" last="1308">
<title>PCBP2 mediates degradation of the adaptor MAVS via the HECT ubiquitin ligase AIP4.</title>
<authorList>
<person name="You F."/>
<person name="Sun H."/>
<person name="Zhou X."/>
<person name="Sun W."/>
<person name="Liang S."/>
<person name="Zhai Z."/>
<person name="Jiang Z."/>
</authorList>
<dbReference type="PubMed" id="19881509"/>
<dbReference type="DOI" id="10.1038/ni.1815"/>
</citation>
<scope>INTERACTION WITH PCBP2</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2010" name="Cell" volume="141" first="483" last="496">
<title>NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways.</title>
<authorList>
<person name="Cui J."/>
<person name="Zhu L."/>
<person name="Xia X."/>
<person name="Wang H.Y."/>
<person name="Legras X."/>
<person name="Hong J."/>
<person name="Ji J."/>
<person name="Shen P."/>
<person name="Zheng S."/>
<person name="Chen Z.J."/>
<person name="Wang R.F."/>
</authorList>
<dbReference type="PubMed" id="20434986"/>
<dbReference type="DOI" id="10.1016/j.cell.2010.03.040"/>
</citation>
<scope>INTERACTION WITH NLRC5</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2010" name="Cell Res." volume="20" first="802" last="811">
<title>The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling.</title>
<authorList>
<person name="Chen R."/>
<person name="Zhang L."/>
<person name="Zhong B."/>
<person name="Tan B."/>
<person name="Liu Y."/>
<person name="Shu H.B."/>
</authorList>
<dbReference type="PubMed" id="20368735"/>
<dbReference type="DOI" id="10.1038/cr.2010.41"/>
</citation>
<scope>UBIQUITINATION</scope>
<scope>DEUBIQUITINATION BY USP17L2</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2010" name="Rheumatology" volume="49" first="433" last="440">
<title>The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody.</title>
<authorList>
<person name="Nakashima R."/>
<person name="Imura Y."/>
<person name="Kobayashi S."/>
<person name="Yukawa N."/>
<person name="Yoshifuji H."/>
<person name="Nojima T."/>
<person name="Kawabata D."/>
<person name="Ohmura K."/>
<person name="Usui T."/>
<person name="Fujii T."/>
<person name="Okawa K."/>
<person name="Mimori T."/>
</authorList>
<dbReference type="PubMed" id="20015976"/>
<dbReference type="DOI" id="10.1093/rheumatology/kep375"/>
</citation>
<scope>INVOLVEMENT IN CLINICALLY AMYOPATHIC DERMATOMYOSITIS</scope>
<scope>IDENTIFICATION AS CADM-140 AUTOANTIGEN</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2011" name="Immunity" volume="34" first="680" last="692">
<title>Immune signaling by RIG-I-like receptors.</title>
<authorList>
<person name="Loo Y.M."/>
<person name="Gale M. Jr."/>
</authorList>
<dbReference type="PubMed" id="21616437"/>
<dbReference type="DOI" id="10.1016/j.immuni.2011.05.003"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2011" name="Immunol. Rev." volume="243" first="91" last="98">
<title>RIG-I-like receptors: cytoplasmic sensors for non-self RNA.</title>
<authorList>
<person name="Kato H."/>
<person name="Takahasi K."/>
<person name="Fujita T."/>
</authorList>
<dbReference type="PubMed" id="21884169"/>
<dbReference type="DOI" id="10.1111/j.1600-065X.2011.01052.x"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2011" name="J. Immunol." volume="187" first="1713" last="1721">
<title>Innate immune responses in human monocyte-derived dendritic cells are highly dependent on the size and the 5' phosphorylation of RNA molecules.</title>
<authorList>
<person name="Jiang M."/>
<person name="Osterlund P."/>
<person name="Sarin L.P."/>
<person name="Poranen M.M."/>
<person name="Bamford D.H."/>
<person name="Guo D."/>
<person name="Julkunen I."/>
</authorList>
<dbReference type="PubMed" id="21742966"/>
<dbReference type="DOI" id="10.4049/jimmunol.1100361"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2011" name="J. Interferon Cytokine Res." volume="31" first="27" last="31">
<title>Retinoic acid-inducible gene-I-like receptors.</title>
<authorList>
<person name="Onoguchi K."/>
<person name="Yoneyama M."/>
<person name="Fujita T."/>
</authorList>
<dbReference type="PubMed" id="20950133"/>
<dbReference type="DOI" id="10.1089/jir.2010.0057"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2011" name="Mol. Cell. Biol." volume="31" first="3802" last="3819">
<title>DDX60, a DEXD/H box helicase, is a novel antiviral factor promoting RIG-I-like receptor-mediated signaling.</title>
<authorList>
<person name="Miyashita M."/>
<person name="Oshiumi H."/>
<person name="Matsumoto M."/>
<person name="Seya T."/>
</authorList>
<dbReference type="PubMed" id="21791617"/>
<dbReference type="DOI" id="10.1128/MCB.01368-10"/>
</citation>
<scope>INTERACTION WITH DDX60</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2011" name="Mol. Immunol." volume="48" first="415" last="422">
<title>MDA5 is SUMOylated by PIAS2? in the upregulation of type I interferon signaling.</title>
<authorList>
<person name="Fu J."/>
<person name="Xiong Y."/>
<person name="Xu Y."/>
<person name="Cheng G."/>
<person name="Tang H."/>
</authorList>
<dbReference type="PubMed" id="21156324"/>
<dbReference type="DOI" id="10.1016/j.molimm.2010.09.003"/>
</citation>
<scope>SUMOYLATION</scope>
<scope>INTERACTION WITH PIAS2-BETA</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2011" name="Nat. Immunol." volume="12" first="114" last="115">
<title>2 methylate or not 2 methylate: viral evasion of the type I interferon response.</title>
<authorList>
<person name="Garcia-Sastre A."/>
</authorList>
<dbReference type="PubMed" id="21245900"/>
<dbReference type="DOI" id="10.1038/ni0211-114"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2011" name="Nat. Immunol." volume="12" first="137" last="143">
<title>Ribose 2'-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5.</title>
<authorList>
<person name="Zuest R."/>
<person name="Cervantes-Barragan L."/>
<person name="Habjan M."/>
<person name="Maier R."/>
<person name="Neuman B.W."/>
<person name="Ziebuhr J."/>
<person name="Szretter K.J."/>
<person name="Baker S.C."/>
<person name="Barchet W."/>
<person name="Diamond M.S."/>
<person name="Siddell S.G."/>
<person name="Ludewig B."/>
<person name="Thiel V."/>
</authorList>
<dbReference type="PubMed" id="21217758"/>
<dbReference type="DOI" id="10.1038/ni.1979"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2011" name="Proc. Natl. Acad. Sci. U.S.A." volume="108" first="21010" last="21015">
<title>Cooperative assembly and dynamic disassembly of MDA5 filaments for viral dsRNA recognition.</title>
<authorList>
<person name="Peisley A."/>
<person name="Lin C."/>
<person name="Wu B."/>
<person name="Orme-Johnson M."/>
<person name="Liu M."/>
<person name="Walz T."/>
<person name="Hur S."/>
</authorList>
<dbReference type="PubMed" id="22160685"/>
<dbReference type="DOI" id="10.1073/pnas.1113651108"/>
</citation>
<scope>SUBUNIT</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2012" name="J. Virol." volume="86" first="3528" last="3540">
<title>Herpes simplex virus 1 tegument protein US11 downmodulates the RLR signaling pathway via direct interaction with RIG-I and MDA-5.</title>
<authorList>
<person name="Xing J."/>
<person name="Wang S."/>
<person name="Lin R."/>
<person name="Mossman K.L."/>
<person name="Zheng C."/>
</authorList>
<dbReference type="PubMed" id="22301138"/>
<dbReference type="DOI" id="10.1128/JVI.06713-11"/>
</citation>
<scope>INTERACTION WITH HERPES SIMPLEX VIRUS 1 PROTEIN US11</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2013" name="FEBS Lett." volume="587" first="2137" last="2142">
<title>A role for the Ankyrin repeat containing protein Ankrd17 in Nod1- and Nod2-mediated inflammatory responses.</title>
<authorList>
<person name="Menning M."/>
<person name="Kufer T.A."/>
</authorList>
<dbReference type="PubMed" id="23711367"/>
<dbReference type="DOI" id="10.1016/j.febslet.2013.05.037"/>
</citation>
<scope>INTERACTION WITH ANKRD17</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="33">
<citation type="journal article" date="2015" name="Cell Rep." volume="11" first="192" last="200">
<title>RIOK3-mediated phosphorylation of MDA5 interferes with its assembly and attenuates the innate immune response.</title>
<authorList>
<person name="Takashima K."/>
<person name="Oshiumi H."/>
<person name="Takaki H."/>
<person name="Matsumoto M."/>
<person name="Seya T."/>
</authorList>
<dbReference type="PubMed" id="25865883"/>
<dbReference type="DOI" id="10.1016/j.celrep.2015.03.027"/>
</citation>
<scope>PHOSPHORYLATION AT SER-828</scope>
<scope>MUTAGENESIS OF SER-828 AND THR-829</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2006" name="Nat. Genet." volume="38" first="617" last="619">
<title>A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region.</title>
<authorList>
<person name="Smyth D.J."/>
<person name="Cooper J.D."/>
<person name="Bailey R."/>
<person name="Field S."/>
<person name="Burren O."/>
<person name="Smink L.J."/>
<person name="Guja C."/>
<person name="Ionescu-Tirgoviste C."/>
<person name="Widmer B."/>
<person name="Dunger D.B."/>
<person name="Savage D.A."/>
<person name="Walker N.M."/>
<person name="Clayton D.G."/>
<person name="Todd J.A."/>
</authorList>
<dbReference type="PubMed" id="16699517"/>
<dbReference type="DOI" id="10.1038/ng1800"/>
</citation>
<scope>VARIANT THR-946</scope>
<scope>POSSIBLE ASSOCIATION WITH IDDM19</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2014" name="Am. J. Hum. Genet." volume="95" first="121" last="125">
<title>Aicardi-Goutieres syndrome is caused by IFIH1 mutations.</title>
<authorList>
<person name="Oda H."/>
<person name="Nakagawa K."/>
<person name="Abe J."/>
<person name="Awaya T."/>
<person name="Funabiki M."/>
<person name="Hijikata A."/>
<person name="Nishikomori R."/>
<person name="Funatsuka M."/>
<person name="Ohshima Y."/>
<person name="Sugawara Y."/>
<person name="Yasumi T."/>
<person name="Kato H."/>
<person name="Shirai T."/>
<person name="Ohara O."/>
<person name="Fujita T."/>
<person name="Heike T."/>
</authorList>
<dbReference type="PubMed" id="24995871"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2014.06.007"/>
</citation>
<scope>INVOLVEMENT IN AGS7</scope>
<scope>VARIANTS AGS7 PHE-372; THR-452 AND HIS-779</scope>
<scope>CHARACTERIZATION OF VARIANTS AGS7 PHE-372; THR-452 AND HIS-779</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2014" name="Nat. Genet." volume="46" first="503" last="509">
<title>Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling.</title>
<authorList>
<person name="Rice G.I."/>
<person name="del Toro Duany Y."/>
<person name="Jenkinson E.M."/>
<person name="Forte G.M."/>
<person name="Anderson B.H."/>
<person name="Ariaudo G."/>
<person name="Bader-Meunier B."/>
<person name="Baildam E.M."/>
<person name="Battini R."/>
<person name="Beresford M.W."/>
<person name="Casarano M."/>
<person name="Chouchane M."/>
<person name="Cimaz R."/>
<person name="Collins A.E."/>
<person name="Cordeiro N.J."/>
<person name="Dale R.C."/>
<person name="Davidson J.E."/>
<person name="De Waele L."/>
<person name="Desguerre I."/>
<person name="Faivre L."/>
<person name="Fazzi E."/>
<person name="Isidor B."/>
<person name="Lagae L."/>
<person name="Latchman A.R."/>
<person name="Lebon P."/>
<person name="Li C."/>
<person name="Livingston J.H."/>
<person name="Lourenco C.M."/>
<person name="Mancardi M.M."/>
<person name="Masurel-Paulet A."/>
<person name="McInnes I.B."/>
<person name="Menezes M.P."/>
<person name="Mignot C."/>
<person name="O'Sullivan J."/>
<person name="Orcesi S."/>
<person name="Picco P.P."/>
<person name="Riva E."/>
<person name="Robinson R.A."/>
<person name="Rodriguez D."/>
<person name="Salvatici E."/>
<person name="Scott C."/>
<person name="Szybowska M."/>
<person name="Tolmie J.L."/>
<person name="Vanderver A."/>
<person name="Vanhulle C."/>
<person name="Vieira J.P."/>
<person name="Webb K."/>
<person name="Whitney R.N."/>
<person name="Williams S.G."/>
<person name="Wolfe L.A."/>
<person name="Zuberi S.M."/>
<person name="Hur S."/>
<person name="Crow Y.J."/>
</authorList>
<dbReference type="PubMed" id="24686847"/>
<dbReference type="DOI" id="10.1038/ng.2933"/>
</citation>
<scope>INVOLVEMENT IN AGS7</scope>
<scope>VARIANTS AGS7 GLY-337; VAL-393; ARG-495; GLN-720; HIS-779 AND CYS-779</scope>
<scope>CHARACTERIZATION OF VARIANTS AGS7 GLY-337; VAL-393; ARG-495; GLN-720; HIS-779 AND CYS-779</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2015" name="Am. J. Hum. Genet." volume="96" first="275" last="282">
<title>A specific IFIH1 gain-of-function mutation causes Singleton-Merten syndrome.</title>
<authorList>
<person name="Rutsch F."/>
<person name="MacDougall M."/>
<person name="Lu C."/>
<person name="Buers I."/>
<person name="Mamaeva O."/>
<person name="Nitschke Y."/>
<person name="Rice G.I."/>
<person name="Erlandsen H."/>
<person name="Kehl H.G."/>
<person name="Thiele H."/>
<person name="Nurnberg P."/>
<person name="Hohne W."/>
<person name="Crow Y.J."/>
<person name="Feigenbaum A."/>
<person name="Hennekam R.C."/>
</authorList>
<dbReference type="PubMed" id="25620204"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2014.12.014"/>
</citation>
<scope>INVOLVEMENT IN SGMRT1</scope>
<scope>VARIANT SGMRT1 GLN-822</scope>
<scope>CHARACTERIZATION OF VARIANT SGMRT1 GLN-822</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2009" name="Arch. Biochem. Biophys." volume="488" first="23" last="33">
<title>Structural basis of double-stranded RNA recognition by the RIG-I like receptor MDA5.</title>
<authorList>
<person name="Li X."/>
<person name="Lu C."/>
<person name="Stewart M."/>
<person name="Xu H."/>
<person name="Strong R.K."/>
<person name="Igumenova T."/>
<person name="Li P."/>
</authorList>
<dbReference type="PubMed" id="19531363"/>
<dbReference type="DOI" id="10.1016/j.abb.2009.06.008"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.45 ANGSTROMS) OF 893-1017 IN COMPLEX WITH ZINC IONS</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="17465" last="17474">
<title>Solution structures of cytosolic RNA sensor MDA5 and LGP2 C-terminal domains: identification of the RNA recognition loop in RIG-I-like receptors.</title>
<authorList>
<person name="Takahasi K."/>
<person name="Kumeta H."/>
<person name="Tsuduki N."/>
<person name="Narita R."/>
<person name="Shigemoto T."/>
<person name="Hirai R."/>
<person name="Yoneyama M."/>
<person name="Horiuchi M."/>
<person name="Ogura K."/>
<person name="Fujita T."/>
<person name="Inagaki F."/>
</authorList>
<dbReference type="PubMed" id="19380577"/>
<dbReference type="DOI" id="10.1074/jbc.M109.007179"/>
</citation>
<scope>STRUCTURE BY NMR OF 896-1025 IN COMPLEX WITH ZINC IONS</scope>
</reference>
<reference key="40">
<citation type="submission" date="2009-02" db="PDB data bank">
<title>Human dech-box RNA helicase mda5 (melanoma differentiation-associated protein 5), dech-domain.</title>
<authorList>
<consortium name="Structural genomics consortium (SGC)"/>
</authorList>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 277-490</scope>
</reference>
<comment type="function">
<text evidence="10 19 23 29 30">Innate immune receptor which acts as a cytoplasmic sensor of viral nucleic acids and plays a major role in sensing viral infection and in the activation of a cascade of antiviral responses including the induction of type I interferons and proinflammatory cytokines. Its ligands include mRNA lacking 2'-O-methylation at their 5' cap and long-dsRNA (>1 kb in length). Upon ligand binding it associates with mitochondria antiviral signaling protein (MAVS/IPS1) which activates the IKK-related kinases: TBK1 and IKBKE which phosphorylate interferon regulatory factors: IRF3 and IRF7 which in turn activate transcription of antiviral immunological genes, including interferons (IFNs); IFN-alpha and IFN-beta. Responsible for detecting the Picornaviridae family members such as encephalomyocarditis virus (EMCV) and mengo encephalomyocarditis virus (ENMG). Can also detect other viruses such as dengue virus (DENV), west Nile virus (WNV), and reovirus. Also involved in antiviral signaling in response to viruses containing a dsDNA genome, such as vaccinia virus. Plays an important role in amplifying innate immune signaling through recognition of RNA metabolites that are produced during virus infection by ribonuclease L (RNase L). May play an important role in enhancing natural killer cell function and may be involved in growth inhibition and apoptosis in several tumor cell lines.</text>
</comment>
<comment type="catalytic activity">
<text>ATP + H(2)O = ADP + phosphate.</text>
</comment>
<comment type="subunit">
<text evidence="13 14 15 18 20 21 24 27 28 31 32 33 34">Monomer in the absence of ligands and homodimerizes in the presence of dsRNA ligands. Can assemble into helical or linear polymeric filaments on long dsRNA. Interacts with MAVS/IPS1. Interacts (via the CARD domains) with TKFC, the interaction is inhibited by viral infection (PubMed:17600090). Interacts with PCBP2. Interacts with NLRC5. Interacts with PIAS2-beta. Interacts with DDX60. Interacts with ANKRD17. Interacts with IKBKE (PubMed:17600090). Interacts with V protein of Simian virus 5, Human parainfluenza virus 2, Mumps virus, Sendai virus and Hendra virus. Binding to paramyxoviruses V proteins prevents IFN-beta induction, and the further establishment of an antiviral state. Interacts with herpes simplex virus 1 protein US11; this interaction prevents the interaction of MAVS/IPS1 to IFIH1.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-6115771"/>
<interactant intactId="EBI-6115771"/>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-6115771"/>
<interactant intactId="EBI-995373">
<id>Q7Z434</id>
<label>MAVS</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-6115771"/>
<interactant intactId="EBI-6148694">
<id>P11207</id>
<label>P/V</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-6115771"/>
<interactant intactId="EBI-6599165">
<id>P30927</id>
<label>P/V</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-6115771"/>
<interactant intactId="EBI-6598728">
<id>Q9EMA9</id>
<label>P/V</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-6115771"/>
<interactant intactId="EBI-1047061">
<id>O14730</id>
<label>RIOK3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-6115771"/>
<interactant intactId="EBI-6150681">
<id>P04487</id>
<label>US11</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="8 10">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="40">Nucleus</location>
</subcellularLocation>
<text>May be found in the nucleus, during apoptosis.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q9BYX4-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q9BYX4-2</id>
<name>2</name>
<sequence type="described" ref="VSP_013337 VSP_013338"/>
<text>No experimental confirmation available.</text>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="8 9 10">Widely expressed, at a low level. Expression is detected at slightly highest levels in placenta, pancreas and spleen and at barely levels in detectable brain, testis and lung.</text>
</comment>
<comment type="induction">
<text evidence="8">By interferon (IFN) and TNF.</text>
</comment>
<comment type="PTM">
<text evidence="28">Sumoylated. Sumoylation positively regulates its role in type I interferon induction and is enhanced by PIAS2-beta.</text>
</comment>
<comment type="PTM">
<text evidence="17 26">Ubiquitinated by RNF125, leading to its degradation by the proteasome (PubMed:17460044). USP17/UPS17L2-dependent deubiquitination positively regulates the receptor (PubMed:20368735).</text>
</comment>
<comment type="PTM">
<text evidence="4">During apoptosis, processed into 3 cleavage products. The helicase-containing fragment, once liberated from the CARD domains, translocate from the cytoplasm to the nucleus. The processed protein significantly sensitizes cells to DNA degradation.</text>
</comment>
<comment type="disease" evidence="16">
<disease id="DI-02778">
<name>Diabetes mellitus, insulin-dependent, 19</name>
<acronym>IDDM19</acronym>
<description>A multifactorial disorder of glucose homeostasis that is characterized by susceptibility to ketoacidosis in the absence of insulin therapy. Clinical features are polydipsia, polyphagia and polyuria which result from hyperglycemia-induced osmotic diuresis and secondary thirst. These derangements result in long-term complications that affect the eyes, kidneys, nerves, and blood vessels.</description>
<dbReference type="MIM" id="610155"/>
</disease>
<text>Disease susceptibility may be associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<text evidence="22 25">IFIH1 is the CADM-140 autoantigen, involved in clinically amyopathic dermatomyositis (CADM). This is a chronic inflammatory disorder that shows typical skin manifestations of dermatomyositis but has no or little evidence of clinical myositis. Anti-CADM-140 antibodies appear to be specific to dermatomyositis, especially CADM. Patients with anti-CADM-140 antibodies frequently develop life-threatening acute progressive interstitial lung disease (ILD).</text>
</comment>
<comment type="disease" evidence="35 36">
<disease id="DI-04126">
<name>Aicardi-Goutieres syndrome 7</name>
<acronym>AGS7</acronym>
<description>A form of Aicardi-Goutieres syndrome, a genetically heterogeneous disease characterized by cerebral atrophy, leukoencephalopathy, intracranial calcifications, chronic cerebrospinal fluid (CSF) lymphocytosis, increased CSF alpha-interferon, and negative serologic investigations for common prenatal infection. Clinical features as thrombocytopenia, hepatosplenomegaly and elevated hepatic transaminases along with intermittent fever may erroneously suggest an infective process. Severe neurological dysfunctions manifest in infancy as progressive microcephaly, spasticity, dystonic posturing and profound psychomotor retardation. Death often occurs in early childhood.</description>
<dbReference type="MIM" id="615846"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="37">
<disease id="DI-04386">
<name>Singleton-Merten syndrome 1</name>
<acronym>SGMRT1</acronym>
<description>An autosomal dominant disorder with variable expression. Core features are marked aortic calcification, dental anomalies, osteopenia, acro-osteolysis, and to a lesser extend glaucoma, psoriasis, muscle weakness, and joint laxity. Dental anomalies include delayed eruption and immature root formation of anterior permanent teeth, early loss of permanent teeth due to short roots, acute root resorption, high caries, and aggressive alveolar bone loss. Additional clinical manifestations include particular facial characteristics and abnormal joint and muscle ligaments.</description>
<dbReference type="MIM" id="182250"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<text>In HIV-1 infected HeLa-CD4 cells, overexpression of IFIH1 results in a great increase in the level of secreted viral p24 protein.</text>
</comment>
<comment type="similarity">
<text evidence="40">Belongs to the helicase family. RLR subfamily.</text>
</comment>
<comment type="sequence caution" evidence="40">
<conflict type="miscellaneous discrepancy">
<sequence resource="EMBL-CDS" id="AAH78180" version="1"/>
</conflict>
<text>Contaminating sequence. Potential poly-A sequence.</text>
</comment>
<comment type="sequence caution" evidence="40">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAB71141" version="1"/>
</conflict>
<text>Translation N-terminally extended.</text>
</comment>
<dbReference type="EC" id="3.6.4.13"/>
<dbReference type="EMBL" id="AF095844">
<property type="protein sequence ID" value="AAG34368.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY017378">
<property type="protein sequence ID" value="AAG54076.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC046208">
<property type="protein sequence ID" value="AAH46208.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC078180">
<property type="protein sequence ID" value="AAH78180.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC111750">
<property type="protein sequence ID" value="AAI11751.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK056293">
<property type="protein sequence ID" value="BAB71141.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS2217.1">
<molecule id="Q9BYX4-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_071451.2">
<molecule id="Q9BYX4-1"/>
<property type="nucleotide sequence ID" value="NM_022168.3"/>
</dbReference>
<dbReference type="UniGene" id="Hs.163173"/>
<dbReference type="PDB" id="2RQB">
<property type="method" value="NMR"/>
<property type="chains" value="A=896-1025"/>
</dbReference>
<dbReference type="PDB" id="3B6E">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="A=277-490"/>
</dbReference>
<dbReference type="PDB" id="3GA3">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.45"/>
<property type="chains" value="A=893-1017"/>
</dbReference>
<dbReference type="PDB" id="4GL2">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.56"/>
<property type="chains" value="A/B=306-1017"/>
</dbReference>
<dbReference type="PDBsum" id="2RQB"/>
<dbReference type="PDBsum" id="3B6E"/>
<dbReference type="PDBsum" id="3GA3"/>
<dbReference type="PDBsum" id="4GL2"/>
<dbReference type="ProteinModelPortal" id="Q9BYX4"/>
<dbReference type="SMR" id="Q9BYX4"/>
<dbReference type="BioGrid" id="122082">
<property type="interactions" value="15"/>
</dbReference>
<dbReference type="DIP" id="DIP-42607N"/>
<dbReference type="IntAct" id="Q9BYX4">
<property type="interactions" value="21"/>
</dbReference>
<dbReference type="MINT" id="MINT-3381993"/>
<dbReference type="STRING" id="9606.ENSP00000263642"/>
<dbReference type="iPTMnet" id="Q9BYX4"/>
<dbReference type="PhosphoSitePlus" id="Q9BYX4"/>
<dbReference type="BioMuta" id="IFIH1"/>
<dbReference type="DMDM" id="134047802"/>
<dbReference type="EPD" id="Q9BYX4"/>
<dbReference type="MaxQB" id="Q9BYX4"/>
<dbReference type="PaxDb" id="Q9BYX4"/>
<dbReference type="PeptideAtlas" id="Q9BYX4"/>
<dbReference type="PRIDE" id="Q9BYX4"/>
<dbReference type="Ensembl" id="ENST00000263642">
<molecule id="Q9BYX4-1"/>
<property type="protein sequence ID" value="ENSP00000263642"/>
<property type="gene ID" value="ENSG00000115267"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000421365">
<molecule id="Q9BYX4-2"/>
<property type="protein sequence ID" value="ENSP00000408450"/>
<property type="gene ID" value="ENSG00000115267"/>
</dbReference>
<dbReference type="GeneID" id="64135"/>
<dbReference type="KEGG" id="hsa:64135"/>
<dbReference type="UCSC" id="uc002uce.5">
<molecule id="Q9BYX4-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="64135"/>
<dbReference type="DisGeNET" id="64135"/>
<dbReference type="GeneCards" id="IFIH1"/>
<dbReference type="HGNC" id="HGNC:18873">
<property type="gene designation" value="IFIH1"/>
</dbReference>
<dbReference type="HPA" id="HPA002656"/>
<dbReference type="MalaCards" id="IFIH1"/>
<dbReference type="MIM" id="182250">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="606951">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="610155">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="615846">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q9BYX4"/>
<dbReference type="OpenTargets" id="ENSG00000115267"/>
<dbReference type="Orphanet" id="51">
<property type="disease" value="Aicardi-Goutieres syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA134889215"/>
<dbReference type="eggNOG" id="KOG0354">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG1111">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00510000046789"/>
<dbReference type="HOGENOM" id="HOG000230992"/>
<dbReference type="HOVERGEN" id="HBG106019"/>
<dbReference type="InParanoid" id="Q9BYX4"/>
<dbReference type="KO" id="K12647"/>
<dbReference type="OMA" id="EIICKCG"/>
<dbReference type="OrthoDB" id="EOG091G01PQ"/>
<dbReference type="PhylomeDB" id="Q9BYX4"/>
<dbReference type="TreeFam" id="TF330258"/>
<dbReference type="Reactome" id="R-HSA-168928">
<property type="pathway name" value="RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5689880">
<property type="pathway name" value="Ub-specific processing proteases"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5689896">
<property type="pathway name" value="Ovarian tumor domain proteases"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-918233">
<property type="pathway name" value="TRAF3-dependent IRF activation pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-933541">
<property type="pathway name" value="TRAF6 mediated IRF7 activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-933542">
<property type="pathway name" value="TRAF6 mediated NF-kB activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-933543">
<property type="pathway name" value="NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-936440">
<property type="pathway name" value="Negative regulators of RIG-I/MDA5 signaling"/>
</dbReference>
<dbReference type="ChiTaRS" id="IFIH1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q9BYX4"/>
<dbReference type="GeneWiki" id="MDA5"/>
<dbReference type="GenomeRNAi" id="64135"/>
<dbReference type="PRO" id="PR:Q9BYX4"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 2"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000115267"/>
<dbReference type="CleanEx" id="HS_IFIH1"/>
<dbReference type="Genevisible" id="Q9BYX4">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0003725">
<property type="term" value="F:double-stranded RNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004386">
<property type="term" value="F:helicase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0043021">
<property type="term" value="F:ribonucleoprotein complex binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003727">
<property type="term" value="F:single-stranded RNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0039528">
<property type="term" value="P:cytoplasmic pattern recognition receptor signaling pathway in response to virus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009597">
<property type="term" value="P:detection of virus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0039530">
<property type="term" value="P:MDA-5 signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032480">
<property type="term" value="P:negative regulation of type I interferon production"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0032727">
<property type="term" value="P:positive regulation of interferon-alpha production"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032728">
<property type="term" value="P:positive regulation of interferon-beta production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016579">
<property type="term" value="P:protein deubiquitination"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016925">
<property type="term" value="P:protein sumoylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034344">
<property type="term" value="P:regulation of type III interferon production"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009615">
<property type="term" value="P:response to virus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="InterPro" id="IPR031964">
<property type="entry name" value="CARD_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR006935">
<property type="entry name" value="Helicase/UvrB_N"/>
</dbReference>
<dbReference type="InterPro" id="IPR014001">
<property type="entry name" value="Helicase_ATP-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR001650">
<property type="entry name" value="Helicase_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR027417">
<property type="entry name" value="P-loop_NTPase"/>
</dbReference>
<dbReference type="InterPro" id="IPR021673">
<property type="entry name" value="RLR_CTR"/>
</dbReference>
<dbReference type="Pfam" id="PF16739">
<property type="entry name" value="CARD_2"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF00271">
<property type="entry name" value="Helicase_C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF04851">
<property type="entry name" value="ResIII"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF11648">
<property type="entry name" value="RIG-I_C-RD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00487">
<property type="entry name" value="DEXDc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00490">
<property type="entry name" value="HELICc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52540">
<property type="entry name" value="SSF52540"/>
<property type="match status" value="6"/>
</dbReference>
<dbReference type="PROSITE" id="PS51192">
<property type="entry name" value="HELICASE_ATP_BIND_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51194">
<property type="entry name" value="HELICASE_CTER"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51789">
<property type="entry name" value="RLR_CTR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0948">Aicardi-Goutieres syndrome</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0051">Antiviral defense</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0219">Diabetes mellitus</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0347">Helicase</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0694">RNA-binding</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0862">Zinc</keyword>
<feature type="chain" description="Interferon-induced helicase C domain-containing protein 1" id="PRO_0000102012">
<location>
<begin position="1"/>
<end position="1025"/>
</location>
</feature>
<feature type="domain" description="CARD 1">
<location>
<begin position="7"/>
<end position="97"/>
</location>
</feature>
<feature type="domain" description="CARD 2">
<location>
<begin position="110"/>
<end position="190"/>
</location>
</feature>
<feature type="domain" description="Helicase ATP-binding" evidence="5">
<location>
<begin position="316"/>
<end position="509"/>
</location>
</feature>
<feature type="domain" description="Helicase C-terminal" evidence="6">
<location>
<begin position="700"/>
<end position="882"/>
</location>
</feature>
<feature type="domain" description="RLR CTR" evidence="7">
<location>
<begin position="893"/>
<end position="1020"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="7">
<location>
<position position="907"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="7">
<location>
<position position="910"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="7">
<location>
<position position="962"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="7">
<location>
<position position="964"/>
</location>
</feature>
<feature type="site" description="Cleavage" evidence="3">
<location>
<begin position="208"/>
<end position="209"/>
</location>
</feature>
<feature type="site" description="Cleavage" evidence="3">
<location>
<begin position="216"/>
<end position="217"/>
</location>
</feature>
<feature type="site" description="Cleavage" evidence="3">
<location>
<begin position="251"/>
<end position="252"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="289"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="291"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="301"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="645"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by RIOK3" evidence="38">
<location>
<position position="828"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_013337" evidence="39">
<original>EIENLSQVDGPQVE</original>
<variation>GICNFTEEDSSNSA</variation>
<location>
<begin position="208"/>
<end position="221"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_013338" evidence="39">
<location>
<begin position="222"/>
<end position="1025"/>
</location>
</feature>
<feature type="sequence variant" description="In AGS7; enhances the interferon signaling pathway activation; enhances the stability of filament formation; enhances dsRNA binding activity; no loss of ATP hydrolysis; dbSNP:rs587777447." id="VAR_071375" evidence="35">
<original>R</original>
<variation>G</variation>
<location>
<position position="337"/>
</location>
</feature>
<feature type="sequence variant" description="In AGS7; enhances IFNB1 promoter activation; loss of ligand-induced responsiveness; dbSNP:rs587777576." id="VAR_071376" evidence="36">
<original>L</original>
<variation>F</variation>
<location>
<position position="372"/>
</location>
</feature>
<feature type="sequence variant" description="In AGS7; enhances the interferon signaling pathway activation; enhances the stability of filament formation; enhances dsRNA binding activity; no loss of ATP hydrolysis; dbSNP:rs587777449." id="VAR_071377" evidence="35">
<original>D</original>
<variation>V</variation>
<location>
<position position="393"/>
</location>
</feature>
<feature type="sequence variant" description="In AGS7; enhances IFNB1 promoter activation; loss of ligand-induced responsiveness; dbSNP:rs587777575." id="VAR_071378" evidence="36">
<original>A</original>
<variation>T</variation>
<location>
<position position="452"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs10930046." id="VAR_031226">
<original>H</original>
<variation>R</variation>
<location>
<position position="460"/>
</location>
</feature>
<feature type="sequence variant" description="In AGS7; enhances the interferon signaling pathway activation; enhances the stability of filament formation; enhances dsRNA binding activity; no loss of ATP hydrolysis; dbSNP:rs672601336." id="VAR_071379" evidence="35">
<original>G</original>
<variation>R</variation>
<location>
<position position="495"/>
</location>
</feature>
<feature type="sequence variant" description="In AGS7; enhances the interferon signaling pathway activation; enhances the stability of filament formation; enhances dsRNA binding activity; no loss of ATP hydrolysis; dbSNP:rs587777445." id="VAR_071380" evidence="35">
<original>R</original>
<variation>Q</variation>
<location>
<position position="720"/>
</location>
</feature>
<feature type="sequence variant" description="In AGS7; enhances the interferon signaling pathway activation; enhances the stability of filament formation; enhances dsRNA binding activity; no loss of ATP hydrolysis; dbSNP:rs587777448." id="VAR_071381" evidence="35">
<original>R</original>
<variation>C</variation>
<location>
<position position="779"/>
</location>
</feature>
<feature type="sequence variant" description="In AGS7; enhances the interferon signaling pathway activation; enhances the stability of filament formation; enhances dsRNA binding activity; enhances IFNB1 promoter activation; no loss of ATP hydrolysis; dbSNP:rs587777446." id="VAR_071382" evidence="35 36">
<original>R</original>
<variation>H</variation>
<location>
<position position="779"/>
</location>
</feature>
<feature type="sequence variant" description="In SGMRT1; gain-of-function mutation resulting in enhanced INFB1 induction; dbSNP:rs376048533." id="VAR_073666" evidence="37">
<original>R</original>
<variation>Q</variation>
<location>
<position position="822"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3747517." id="VAR_021594" evidence="10 11 12">
<original>H</original>
<variation>R</variation>
<location>
<position position="843"/>
</location>
</feature>
<feature type="sequence variant" description="Associated with susceptibility to IDDM19; dbSNP:rs1990760." id="VAR_021595" evidence="11 12 16">
<original>A</original>
<variation>T</variation>
<location>
<position position="946"/>
</location>
</feature>
<feature type="mutagenesis site" description="No cleavage and no acceleration of DNA degradation." evidence="9">
<original>D</original>
<variation>A</variation>
<location>
<position position="251"/>
</location>
</feature>
<feature type="mutagenesis site" description="No acceleration of DNA degradation, no binding to ATP, and no helicase activity." evidence="9">
<original>E</original>
<variation>A</variation>
<location>
<position position="444"/>
</location>
</feature>
<feature type="mutagenesis site" description="Promotes multimerization after polyI:C stimulation; greatly enhances signaling." evidence="38">
<original>S</original>
<variation>A</variation>
<location>
<position position="828"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits multimerization after polyI:C stimulation." evidence="38">
<original>S</original>
<variation>D</variation>
<location>
<position position="828"/>
</location>
</feature>
<feature type="mutagenesis site" description="Moderately increases signaling." evidence="38">
<original>T</original>
<variation>A</variation>
<location>
<position position="829"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAG54076." ref="2" evidence="40">
<original>L</original>
<variation>F</variation>
<location>
<position position="439"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; BAB71141." ref="4" evidence="40">
<original>N</original>
<variation>H</variation>
<location>
<position position="475"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAG34368." ref="1" evidence="40">
<original>E</original>
<variation>K</variation>
<location>
<position position="592"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAG54076." ref="2" evidence="40">
<original>R</original>
<variation>S</variation>
<location>
<position position="598"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAG54076." ref="2" evidence="40">
<original>E</original>
<variation>K</variation>
<location>
<position position="609"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; BAB71141." ref="4" evidence="40">
<original>K</original>
<variation>R</variation>
<location>
<position position="782"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="293"/>
<end position="299"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="310"/>
<end position="320"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="325"/>
<end position="328"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="332"/>
<end position="352"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="359"/>
<end position="365"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="366"/>
<end position="375"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="377"/>
<end position="381"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="382"/>
<end position="384"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="387"/>
<end position="389"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="400"/>
<end position="406"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="408"/>
<end position="413"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="414"/>
<end position="422"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="434"/>
<end position="436"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="438"/>
<end position="442"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="454"/>
<end position="473"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="483"/>
<end position="488"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="900"/>
<end position="902"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="903"/>
<end position="907"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="908"/>
<end position="910"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="913"/>
<end position="916"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="917"/>
<end position="919"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="921"/>
<end position="923"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="924"/>
<end position="926"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="927"/>
<end position="929"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="934"/>
<end position="937"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="938"/>
<end position="942"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="945"/>
<end position="947"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="955"/>
<end position="962"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="967"/>
<end position="974"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="977"/>
<end position="982"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="984"/>
<end position="986"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="987"/>
<end position="991"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="992"/>
<end position="995"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="996"/>
<end position="998"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="1003"/>
<end position="1005"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="1015"/>
<end position="1017"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3B6E"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3GA3"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250"/>
<evidence key="4" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q8R5F7"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00541"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00542"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU01125"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11805321"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12015121"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14645903"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15563593"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16127453"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16177806"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16699517"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17460044"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17600090"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19211564"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19380577"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19531363"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19565506"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19656871"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19881509"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20015976"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20368735"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20434986"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21156324"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21217758"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21742966"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21791617"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22160685"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22301138"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23711367"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24686847"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24995871"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25620204"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25865883"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000305"/>
<sequence length="1025" mass="116689" checksum="789CFB4824B92DC9" modified="2007-03-20" version="3">
MSNGYSTDENFRYLISCFRARVKMYIQVEPVLDYLTFLPAEVKEQIQRTVATSGNMQAVE
LLLSTLEKGVWHLGWTREFVEALRRTGSPLAARYMNPELTDLPSPSFENAHDEYLQLLNL
LQPTLVDKLLVRDVLDKCMEEELLTIEDRNRIAAAENNGNESGVRELLKRIVQKENWFSA
FLNVLRQTGNNELVQELTGSDCSESNAEIENLSQVDGPQVEEQLLSTTVQPNLEKEVWGM
ENNSSESSFADSSVVSESDTSLAEGSVSCLDESLGHNSNMGSDSGTMGSDSDEENVAARA
SPEPELQLRPYQMEVAQPALEGKNIIICLPTGSGKTRVAVYIAKDHLDKKKKASEPGKVI
VLVNKVLLVEQLFRKEFQPFLKKWYRVIGLSGDTQLKISFPEVVKSCDIIISTAQILENS
LLNLENGEDAGVQLSDFSLIIIDECHHTNKEAVYNNIMRHYLMQKLKNNRLKKENKPVIP
LPQILGLTASPGVGGATKQAKAEEHILKLCANLDAFTIKTVKENLDQLKNQIQEPCKKFA
IADATREDPFKEKLLEIMTRIQTYCQMSPMSDFGTQPYEQWAIQMEKKAAKEGNRKERVC
AEHLRKYNEALQINDTIRMIDAYTHLETFYNEEKDKKFAVIEDDSDEGGDDEYCDGDEDE
DDLKKPLKLDETDRFLMTLFFENNKMLKRLAENPEYENEKLTKLRNTIMEQYTRTEESAR
GIIFTKTRQSAYALSQWITENEKFAEVGVKAHHLIGAGHSSEFKPMTQNEQKEVISKFRT
GKINLLIATTVAEEGLDIKECNIVIRYGLVTNEIAMVQARGRARADESTYVLVAHSGSGV
IEHETVNDFREKMMYKAIHCVQNMKPEEYAHKILELQMQSIMEKKMKTKRNIAKHYKNNP
SLITFLCKNCSVLACSGEDIHVIEKMHHVNMTPEFKELYIVRENKALQKKCADYQINGEI
ICKCGQAWGTMMVHKGLDLPCLKIRNFVVVFKNNSTKKQYKKWVELPITFPNLDYSECCL
FSDED
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>